Document Detail


Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer.
MedLine Citation:
PMID:  8567998     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To investigate the anti Helicobacter pylori (H pylori) spectrotype associated with (a) antral gastritis and duodenal ulcer; (b) the H pylori eradicating treatment. METHODS: Spectrotypic analysis was performed by isoelectric focusing and reverse blotting (IEFRB) in a cross sectional study on sera from 70 patients with antral gastritis and duodenal ulcer. In addition, a longitudinal study was performed on 40 of these patients (20 with antral gastritis and 20 with duodenal ulcer) who underwent eradicating treatment. RESULTS: The cross sectional study showed that the oligoclonal spectrotype was present in 74% of antral gastritis patients and in 85% of duodenal ulcer patients. In only a minority of subjects (23% with antral gastritis and 3% with duodenal ulcer) was a polyclonal spectrotype observed. The longitudinal study showed a reduction in the intensity of the spectrotypic bands in 5/10 antral gastritis patients with eradicated H pylori as opposed to only 2/10 patients without eradication. A reduction was also observed in 6/11 eradicated v 0/9 non-eradicated patients with duodenal ulcer. Collectively, a reduction in the spectrotype was observed in 11/21 patients (52%) who--independently of the disease--underwent H pylori eradication, as opposed to 2/19 of the non-responder patients (10.5%). The polyclonal spectrotype was found exclusively in four patients with antral gastritis, all belonging to the group without eradication of H pylori after eradicating treatment. CONCLUSIONS: The anti H pylori oligoclonal spectrotype is the most common pattern observed in patients with antral gastritis and duodenal ulcer. After H pylori eradicating treatment the spectrotype does not change qualitatively, but the polyclonal pattern seems to be predictive of a poor response to eradication.
Authors:
R Biselli; D Vaira; R Nisini; M Miglioli; L Menegatti; L Barbara; R D'Amelio
Related Documents :
8158588 - Bleeding peptic ulcer: an audit of conservative management.
23020978 - Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el pacient...
11149658 - Unusual polyarthritis as a unique clinical manifestation of coeliac disease.
7111718 - The sensitivity of radiography of the postoperative stomach.
19895908 - Bone marrow-derived progenitors are greatly reduced in patients with severe copd and lo...
1707228 - Role of leukocytes in the activation of intravascular coagulation in patients with sept...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical pathology     Volume:  48     ISSN:  0021-9746     ISO Abbreviation:  J. Clin. Pathol.     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-03-06     Completed Date:  1996-03-06     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0376601     Medline TA:  J Clin Pathol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1117-21     Citation Subset:  AIM; IM    
Affiliation:
Italian Air Force, DASRS, Laboratory of Immunology, Pratica di Mare, Rome.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Antibodies, Bacterial / blood*,  classification
Cross-Sectional Studies
Duodenal Ulcer / immunology*,  microbiology
Female
Follow-Up Studies
Gastritis / immunology*,  microbiology
Helicobacter Infections / drug therapy,  immunology
Helicobacter pylori / immunology*
Humans
Immunoblotting
Isoelectric Focusing
Longitudinal Studies
Male
Middle Aged
Pyloric Antrum
Chemical
Reg. No./Substance:
0/Antibodies, Bacterial
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ten year follow up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a caus...
Next Document:  Quality assessment of Microbe Base antimicrobial susceptibility data.